Jan 10th, 2022

Pfizer CEO Bourla on Acuitas Deal, mRNA Tech, Djokovic

Pfizer Chairman and CEO Albert Bourla discusses the partnership with Acuitas Therapeutics, vaccine development, and tennis star Novak Djokovic's Australian visa reinstatement. He speaks on "Bloomberg Surveillance."

Top Video

Explore More

Duration:3:58

Google Agrees to Create AI Cloud Firm With Blackstone

Exclusive

Duration:4:08

Nvidia's Huang Sees China Becoming a More Open Market

Duration:3:36

Oil Falls as Trump Says He Called Off Iran Strike

Duration:0:59

Tech Stock Pullback Just a Market Pause, NewEdge’s Dawson Says

Duration:1:02

Fast-Moving Sandy Fire Out of Control Near Los Angeles

Duration:2:01

Putin Aims to Unlock Gas Pipeline in Xi Talks

Duration:2:44

EU Officials Rush to Finalize US Trade Deal

Duration:3:06

Ebola Crisis Continues as US Missionary Tests Positive

Duration:3:25

This Bond Selloff Isn't Over Just Yet

The Opening Trade

Duration:1:37

US to Issue New Russia Oil Waiver as Iran War Hits Supplies

Balance of Power

Duration:3:51

Higher for Longer Yields Seen Posing Risk to Equities

The Opening Trade

Duration:2:48

Global Bond Market Jitters Dominate G-7 Talks

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.